High levels of TIMP-1 in plasma or serum were significantly associated with a poor prognosis in CRC patients, based on age-, gender-, grade-, and clinical stage-adjusted hazard ratios [65]. The gene discussed is TIMP1; the disease is colorectal carcinoma.